Company profile: Arbor Biotechnologies
1.1 - Company Overview
Company description
- Provider of next-generation gene editing therapeutics and tools to create targeted genetic medicines for liver and CNS diseases, supported by an AI/ML-powered discovery engine for high-throughput screening. Develops lipid nanoparticle-delivered liver therapies, AAV-delivered CNS therapies, and partners on ex vivo cell-based therapeutics.
Products and services
- Gene Editing Technologies: Arbor Biotechnologies engineers custom-engineered gene editing tools to create targeted genetic medicines, focusing on liver and CNS diseases to treat genetic diseases
- Liver Disease Therapies: The company architects LNP-enabled treatments for liver diseases, using lipid nanoparticles for delivery and aiming for one-time, durable treatments
- Proprietary Discovery Engine: An AI-driven platform utilizes AI/ML with high-throughput screening to discover and optimize novel gene editing technologies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arbor Biotechnologies
Tune Therapeutics
HQ: United States
Website
- Description: Provider of an epigenetic programming platform for disease treatment, offering TEMPO to control gene activity without altering DNA sequence by activating, silencing, or fine-tuning gene output, and TUNE-401, an investigational HBV therapy that epigenetically silences viral DNA in host chromosomes and cccDNA to pursue a functional cure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tune Therapeutics company profile →
Celmatix
HQ: United States
Website
- Description: Provider of preclinical discovery and development focused on women’s ovarian health, including target identification and validation for endometriosis, PCOS, and ovarian senescence; collaborative discovery, development, and commercialization with Evotec and Bayer; contraceptive target discovery supported by the Bill & Melinda Gates Foundation; and proprietary cohorts, annotations, and NLP-driven research tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celmatix company profile →
Rancho BioSciences
HQ: United States
Website
- Description: Provider of fee-for-service life science data curation and knowledge management, leveraging open-source tools and public domain data for Pharma, non-profit foundations, and academia. Services include data curation, data governance and models, bioinformatics analysis (including genetic variant annotation), workflows and pipelines, knowledge mining, and creation of target profiles to support research and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rancho BioSciences company profile →
Diagnoplex
HQ: Switzerland
Website
- Description: Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnoplex company profile →
GenArraytion
HQ: United States
Website
- Description: Provider of medical diagnostics products and services for tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring, including MultiFLEX Bioassays and Sniper Sequencing genotyping services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenArraytion company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arbor Biotechnologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arbor Biotechnologies
2.2 - Growth funds investing in similar companies to Arbor Biotechnologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arbor Biotechnologies
4.2 - Public trading comparable groups for Arbor Biotechnologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →